These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


847 related items for PubMed ID: 23832448

  • 1. Free cholesterol accumulation in hepatic stellate cells: mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice.
    Tomita K, Teratani T, Suzuki T, Shimizu M, Sato H, Narimatsu K, Okada Y, Kurihara C, Irie R, Yokoyama H, Shimamura K, Usui S, Ebinuma H, Saito H, Watanabe C, Komoto S, Kawaguchi A, Nagao S, Sugiyama K, Hokari R, Kanai T, Miura S, Hibi T.
    Hepatology; 2014 Jan; 59(1):154-69. PubMed ID: 23832448
    [Abstract] [Full Text] [Related]

  • 2. A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells.
    Teratani T, Tomita K, Suzuki T, Oshikawa T, Yokoyama H, Shimamura K, Tominaga S, Hiroi S, Irie R, Okada Y, Kurihara C, Ebinuma H, Saito H, Hokari R, Sugiyama K, Kanai T, Miura S, Hibi T.
    Gastroenterology; 2012 Jan; 142(1):152-164.e10. PubMed ID: 21995947
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
    Ota T, Takamura T, Kurita S, Matsuzawa N, Kita Y, Uno M, Akahori H, Misu H, Sakurai M, Zen Y, Nakanuma Y, Kaneko S.
    Gastroenterology; 2007 Jan; 132(1):282-93. PubMed ID: 17241878
    [Abstract] [Full Text] [Related]

  • 6. Cross talk between toll-like receptor-4 signaling and angiotensin-II in liver fibrosis development in the rat model of non-alcoholic steatohepatitis.
    Shirai Y, Yoshiji H, Noguchi R, Kaji K, Aihara Y, Douhara A, Moriya K, Namisaki T, Kawaratani H, Fukui H.
    J Gastroenterol Hepatol; 2013 Apr; 28(4):723-30. PubMed ID: 23301938
    [Abstract] [Full Text] [Related]

  • 7. Tranilast, an antifibrogenic agent, ameliorates a dietary rat model of nonalcoholic steatohepatitis.
    Uno M, Kurita S, Misu H, Ando H, Ota T, Matsuzawa-Nagata N, Kita Y, Nabemoto S, Akahori H, Zen Y, Nakanuma Y, Kaneko S, Takamura T.
    Hepatology; 2008 Jul; 48(1):109-18. PubMed ID: 18571789
    [Abstract] [Full Text] [Related]

  • 8. Vitamin A-coupled liposome system targeting free cholesterol accumulation in hepatic stellate cells offers a beneficial therapeutic strategy for liver fibrosis.
    Furuhashi H, Tomita K, Teratani T, Shimizu M, Nishikawa M, Higashiyama M, Takajo T, Shirakabe K, Maruta K, Okada Y, Kurihara C, Watanabe C, Komoto S, Aosasa S, Nagao S, Yamamoto J, Miura S, Hokari R.
    Hepatol Res; 2018 Apr; 48(5):397-407. PubMed ID: 29243365
    [Abstract] [Full Text] [Related]

  • 9. IFN-γ deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet.
    Luo XY, Takahara T, Kawai K, Fujino M, Sugiyama T, Tsuneyama K, Tsukada K, Nakae S, Zhong L, Li XK.
    Am J Physiol Gastrointest Liver Physiol; 2013 Dec; 305(12):G891-9. PubMed ID: 24136786
    [Abstract] [Full Text] [Related]

  • 10. Rosiglitazone prevents nutritional fibrosis and steatohepatitis in mice.
    Nan YM, Fu N, Wu WJ, Liang BL, Wang RQ, Zhao SX, Zhao JM, Yu J.
    Scand J Gastroenterol; 2009 Dec; 44(3):358-65. PubMed ID: 18991162
    [Abstract] [Full Text] [Related]

  • 11. Metformin ameliorates activation of hepatic stellate cells and hepatic fibrosis by succinate and GPR91 inhibition.
    Nguyen G, Park SY, Le CT, Park WS, Choi DH, Cho EH.
    Biochem Biophys Res Commun; 2018 Jan 22; 495(4):2649-2656. PubMed ID: 29278707
    [Abstract] [Full Text] [Related]

  • 12. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
    Witek RP, Stone WC, Karaca FG, Syn WK, Pereira TA, Agboola KM, Omenetti A, Jung Y, Teaberry V, Choi SS, Guy CD, Pollard J, Charlton P, Diehl AM.
    Hepatology; 2009 Nov 22; 50(5):1421-30. PubMed ID: 19676126
    [Abstract] [Full Text] [Related]

  • 13. Regulation of peroxisome proliferator-activated receptor-gamma activity affects the hepatic stellate cell activation and the progression of NASH via TGF-β1/Smad signaling pathway.
    Ni XX, Li XY, Wang Q, Hua J.
    J Physiol Biochem; 2021 Feb 22; 77(1):35-45. PubMed ID: 33188625
    [Abstract] [Full Text] [Related]

  • 14. Niemann-Pick Type C2 Protein Mediates Hepatic Stellate Cells Activation by Regulating Free Cholesterol Accumulation.
    Twu YC, Lee TS, Lin YL, Hsu SM, Wang YH, Liao CY, Wang CK, Liang YC, Liao YJ.
    Int J Mol Sci; 2016 Jul 13; 17(7):. PubMed ID: 27420058
    [Abstract] [Full Text] [Related]

  • 15. Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice.
    Tomita K, Oike Y, Teratani T, Taguchi T, Noguchi M, Suzuki T, Mizutani A, Yokoyama H, Irie R, Sumimoto H, Takayanagi A, Miyashita K, Akao M, Tabata M, Tamiya G, Ohkura T, Hibi T.
    Hepatology; 2008 Aug 13; 48(2):458-73. PubMed ID: 18666257
    [Abstract] [Full Text] [Related]

  • 16. Adenovirus-mediated peroxisome proliferator activated receptor gamma overexpression prevents nutritional fibrotic steatohepatitis in mice.
    Nan YM, Han F, Kong LB, Zhao SX, Wang RQ, Wu WJ, Yu J.
    Scand J Gastroenterol; 2011 Mar 13; 46(3):358-69. PubMed ID: 20969493
    [Abstract] [Full Text] [Related]

  • 17. Hepatic endothelin-1 and endocannabinoids-dependent effects of hyperleptinemia in nonalcoholic steatohepatitis-cirrhotic rats.
    Yang YY, Tsai TH, Huang YT, Lee TY, Chan CC, Lee KC, Lin HC.
    Hepatology; 2012 May 13; 55(5):1540-50. PubMed ID: 22183953
    [Abstract] [Full Text] [Related]

  • 18. Angiopoietin-like protein 4 deficiency augments liver fibrosis in liver diseases such as nonalcoholic steatohepatitis in mice through enhanced free cholesterol accumulation in hepatic stellate cells.
    Teratani T, Tomita K, Wada A, Sugihara N, Higashiyama M, Inaba K, Horiuchi K, Hanawa Y, Nishii S, Mizoguchi A, Tanemoto R, Ito S, Okada Y, Kurihara C, Akita Y, Narimatsu K, Watanabe C, Komoto S, Oike Y, Miura S, Hokari R, Kanai T.
    Hepatol Res; 2021 May 13; 51(5):580-592. PubMed ID: 33247991
    [Abstract] [Full Text] [Related]

  • 19. VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice.
    Velayudham A, Dolganiuc A, Ellis M, Petrasek J, Kodys K, Mandrekar P, Szabo G.
    Hepatology; 2009 Mar 13; 49(3):989-97. PubMed ID: 19115316
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
    Tu X, Zhang H, Zhang J, Zhao S, Zheng X, Zhang Z, Zhu J, Chen J, Dong L, Zang Y, Zhang J.
    J Pathol; 2014 Sep 13; 234(1):46-59. PubMed ID: 24817606
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 43.